The ubiquitous neuropeptide galanin controls numerous functions such as endocrine secretions, intestinal motility, and behavioral activities. These regulatory effects of galanin are mediated through the interaction with specific membrane receptors and involve the pertussis toxin-sensitive guanine nucleotide binding proteins Gj/G0 as transducing elements. We report here the isolation of a cDNA coding for a human galanin receptor from a Bowes melanoma cell line cDNA expression library, by using a radioligand binding strategy. The nucleotide sequence ofthe cloned receptor reveals an open reading frame encoding a 349-amino acid protein with seven putative hydrophobic transmembrane domains and significant homology with members of the guanine nucleotide binding protein-coupled neuropeptide receptor family. The cloned receptor expressed in COS cells specifically binds human, porcine, and rat galanin with high affinity (Kd in the nanomolar range) and mediates the galanin inhibition of adenylate cyclase. A 2.8-kb galanin receptor transcript was identified in several human tissues. Cloning of this galanin receptor should enhance our knowledge of its distribution, structure, and function in human physiology and pathophysiology.Galanin, a 29-amino acid neuropeptide (30 amino acids in humans), was originally isolated from pig intestine (1) and later reported to be widely distributed in the central and peripheral nervous systems of numerous species (2). Galanin is unrelated to the other known families of regulatory peptides and, to date, remains the only known member of its own family. It exerts multiple regulatory functions such as (i) control of endocrine and exocrine pancreatic secretions, (ii) regulation of intestinal motility, and (iii) modulation of behavioral, cognitive, and sensory functions such as feeding, learning, memory, and nociception (for reviews, see refs. 2 and 3). Galanin exerts its actions via binding to specific membrane receptors (4). Biochemical and molecular studies, performed in brain and pancreas, indicate that the galanin receptor is a glycoprotein of 54 kDa (5-7) coupled to the inhibitory guanine nucleotide binding (G) protein Gi, identified as Gil, Gi2, and Gi3 in pancreatic 83 cells (8,9). Depending on the target tissue, different pathways for intracellular signaling by galanin are involved: inhibition of adenylate cyclase (10), blockage of voltage-dependent Ca2+ channels (11), and activation of ATP-sensitive K+ channels (12). Structure-activity studies, with galanin fragments (13-15) and chimeric peptides (16,17), generally emphasize the importance of the N-terminal fragment of galanin for the interaction with the peptide receptor. These studies also raise the possibility of the existence of galanin receptor subtypes, an issue that may be properly addressed with the molecular cloning of the galanin receptor.In this context, we describe here the expression cloning of a cDNA encoding a galanin receptor from the human Bowes melanoma cell line (18) (vol/vol) fetal calf serum, 6 mM glutami...